Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI
Purpose To assess the diagnostic value of retrospectively fused PET/MRI by comparing the detection rates (DRs) of fused 64 CuCl 2 PET/MRI vs. fused 18 F-Choline PET/MRI in patients with suspected prostatic cancer (PCa) recurrence. The secondary objective was to compare the DRs of fused PET/MRI vs....
Gespeichert in:
| Veröffentlicht in: | Abdominal imaging 2020-11, Vol.45 (11), p.3896-3906 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3906 |
|---|---|
| container_issue | 11 |
| container_start_page | 3896 |
| container_title | Abdominal imaging |
| container_volume | 45 |
| creator | Paparo, Francesco Peirano, Alice Matos, João Bacigalupo, Lorenzo Rossi, Umberto Mussetto, Ilaria Bottoni, Gianluca Ugolini, Martina Introini, Carlo Ruggieri, Filippo Grillo Rollandi, Gian Andrea Piccardo, Arnoldo |
| description | Purpose
To assess the diagnostic value of retrospectively fused PET/MRI by comparing the detection rates (DRs) of fused
64
CuCl
2
PET/MRI vs. fused
18
F-Choline PET/MRI in patients with suspected prostatic cancer (PCa) recurrence. The secondary objective was to compare the DRs of fused PET/MRI vs. those of the separate imaging modalities.
Methods
We retrospectively evaluated 50 PCa patients with biochemical relapse after radical prostatectomy (RP) or radiotherapy (RT). All patients underwent
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and multiparametric magnetic resonance imaging (mpMRI) within 15 days. Fused
64
CuCl
2
-PET/MRI and fused
18
F-Choline PET/MRI images were obtained by retrospective co-registration of MRI and PET images. Experienced readers interpreted the images, and the DRs of each imaging modality were assessed.
Results
In the patient-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 88%, 68%, 82%, 56%, and 74%, respectively. In the lesion-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 95%, 66%, 87%, 58%, and 71%, respectively.
Conclusions
Retrospectively fused PET/MRI is able to overcome the limitations of the separate interpretation of the individual imaging modalities. Fused
64
CuCl
2
PET/MRI provided the highest diagnostic performance in the detection of PCa local relapse. |
| doi_str_mv | 10.1007/s00261-020-02591-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2406949588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2471446569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1977-2615010ffa56db89951f03ca35061610597953651ed8cde49f14a84ca4cfbcf13</originalsourceid><addsrcrecordid>eNp9kUFrFTEUhQdRsNT-AVcBNy469mYmyUzcydhqoaLIE9yFvMxNX0omGZOZlv44_5tpX1VUcBESwnfOTc6pqucUXlGA7iQDNILW0EBZXNK6e1QdNK0QNQDvH_86s69Pq6OcrwCACk5pww-q72-dvgwxL86Qa-1XJNGShEuKeUazuGv0t8SuGUci2LAOviGfTjcnHz6fExfI1kWzw8kZ7YvI6znf6-eiXvSCxOhgML0mJk6zTi7HQG7csnswpP1ZPeyidwF_mh7_MWXYHP8D3d3pMJJpLviz6onVPuPRw35YfTk73Qzv64uP786HNxe1obLr6pIOBwrWai7GbS8lpxZao1sOggoKXHaStyUSHHszIpOWMt0zo5mxW2Npe1i93PuWn31bMS9qctmg9zpgXLNqGAjJJO_7gr74C72KawrldYXqKGOCC1moZk-ZElVOaNWc3KTTraKg7kpV-1JVKVXdl6q6Imr3olzgcInpt_V_VD8ABZegzQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471446569</pqid></control><display><type>article</type><title>Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI</title><source>SpringerLink Journals</source><creator>Paparo, Francesco ; Peirano, Alice ; Matos, João ; Bacigalupo, Lorenzo ; Rossi, Umberto ; Mussetto, Ilaria ; Bottoni, Gianluca ; Ugolini, Martina ; Introini, Carlo ; Ruggieri, Filippo Grillo ; Rollandi, Gian Andrea ; Piccardo, Arnoldo</creator><creatorcontrib>Paparo, Francesco ; Peirano, Alice ; Matos, João ; Bacigalupo, Lorenzo ; Rossi, Umberto ; Mussetto, Ilaria ; Bottoni, Gianluca ; Ugolini, Martina ; Introini, Carlo ; Ruggieri, Filippo Grillo ; Rollandi, Gian Andrea ; Piccardo, Arnoldo</creatorcontrib><description>Purpose
To assess the diagnostic value of retrospectively fused PET/MRI by comparing the detection rates (DRs) of fused
64
CuCl
2
PET/MRI vs. fused
18
F-Choline PET/MRI in patients with suspected prostatic cancer (PCa) recurrence. The secondary objective was to compare the DRs of fused PET/MRI vs. those of the separate imaging modalities.
Methods
We retrospectively evaluated 50 PCa patients with biochemical relapse after radical prostatectomy (RP) or radiotherapy (RT). All patients underwent
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and multiparametric magnetic resonance imaging (mpMRI) within 15 days. Fused
64
CuCl
2
-PET/MRI and fused
18
F-Choline PET/MRI images were obtained by retrospective co-registration of MRI and PET images. Experienced readers interpreted the images, and the DRs of each imaging modality were assessed.
Results
In the patient-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 88%, 68%, 82%, 56%, and 74%, respectively. In the lesion-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 95%, 66%, 87%, 58%, and 71%, respectively.
Conclusions
Retrospectively fused PET/MRI is able to overcome the limitations of the separate interpretation of the individual imaging modalities. Fused
64
CuCl
2
PET/MRI provided the highest diagnostic performance in the detection of PCa local relapse.</description><identifier>ISSN: 2366-004X</identifier><identifier>EISSN: 2366-0058</identifier><identifier>DOI: 10.1007/s00261-020-02591-7</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Cancer surgery ; Choline ; Computed tomography ; Diagnostic systems ; Fluorine isotopes ; Gastroenterology ; Hepatology ; Imaging ; Magnetic resonance imaging ; Medical diagnosis ; Medical imaging ; Medicine ; Medicine & Public Health ; Pelvis ; Positron emission ; Prostate cancer ; Prostatectomy ; Radiation therapy ; Radiology ; Tomography</subject><ispartof>Abdominal imaging, 2020-11, Vol.45 (11), p.3896-3906</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1977-2615010ffa56db89951f03ca35061610597953651ed8cde49f14a84ca4cfbcf13</citedby><cites>FETCH-LOGICAL-c1977-2615010ffa56db89951f03ca35061610597953651ed8cde49f14a84ca4cfbcf13</cites><orcidid>0000-0002-2391-0635</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00261-020-02591-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00261-020-02591-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids></links><search><creatorcontrib>Paparo, Francesco</creatorcontrib><creatorcontrib>Peirano, Alice</creatorcontrib><creatorcontrib>Matos, João</creatorcontrib><creatorcontrib>Bacigalupo, Lorenzo</creatorcontrib><creatorcontrib>Rossi, Umberto</creatorcontrib><creatorcontrib>Mussetto, Ilaria</creatorcontrib><creatorcontrib>Bottoni, Gianluca</creatorcontrib><creatorcontrib>Ugolini, Martina</creatorcontrib><creatorcontrib>Introini, Carlo</creatorcontrib><creatorcontrib>Ruggieri, Filippo Grillo</creatorcontrib><creatorcontrib>Rollandi, Gian Andrea</creatorcontrib><creatorcontrib>Piccardo, Arnoldo</creatorcontrib><title>Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI</title><title>Abdominal imaging</title><addtitle>Abdom Radiol</addtitle><description>Purpose
To assess the diagnostic value of retrospectively fused PET/MRI by comparing the detection rates (DRs) of fused
64
CuCl
2
PET/MRI vs. fused
18
F-Choline PET/MRI in patients with suspected prostatic cancer (PCa) recurrence. The secondary objective was to compare the DRs of fused PET/MRI vs. those of the separate imaging modalities.
Methods
We retrospectively evaluated 50 PCa patients with biochemical relapse after radical prostatectomy (RP) or radiotherapy (RT). All patients underwent
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and multiparametric magnetic resonance imaging (mpMRI) within 15 days. Fused
64
CuCl
2
-PET/MRI and fused
18
F-Choline PET/MRI images were obtained by retrospective co-registration of MRI and PET images. Experienced readers interpreted the images, and the DRs of each imaging modality were assessed.
Results
In the patient-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 88%, 68%, 82%, 56%, and 74%, respectively. In the lesion-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 95%, 66%, 87%, 58%, and 71%, respectively.
Conclusions
Retrospectively fused PET/MRI is able to overcome the limitations of the separate interpretation of the individual imaging modalities. Fused
64
CuCl
2
PET/MRI provided the highest diagnostic performance in the detection of PCa local relapse.</description><subject>Cancer surgery</subject><subject>Choline</subject><subject>Computed tomography</subject><subject>Diagnostic systems</subject><subject>Fluorine isotopes</subject><subject>Gastroenterology</subject><subject>Hepatology</subject><subject>Imaging</subject><subject>Magnetic resonance imaging</subject><subject>Medical diagnosis</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pelvis</subject><subject>Positron emission</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Radiation therapy</subject><subject>Radiology</subject><subject>Tomography</subject><issn>2366-004X</issn><issn>2366-0058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kUFrFTEUhQdRsNT-AVcBNy469mYmyUzcydhqoaLIE9yFvMxNX0omGZOZlv44_5tpX1VUcBESwnfOTc6pqucUXlGA7iQDNILW0EBZXNK6e1QdNK0QNQDvH_86s69Pq6OcrwCACk5pww-q72-dvgwxL86Qa-1XJNGShEuKeUazuGv0t8SuGUci2LAOviGfTjcnHz6fExfI1kWzw8kZ7YvI6znf6-eiXvSCxOhgML0mJk6zTi7HQG7csnswpP1ZPeyidwF_mh7_MWXYHP8D3d3pMJJpLviz6onVPuPRw35YfTk73Qzv64uP786HNxe1obLr6pIOBwrWai7GbS8lpxZao1sOggoKXHaStyUSHHszIpOWMt0zo5mxW2Npe1i93PuWn31bMS9qctmg9zpgXLNqGAjJJO_7gr74C72KawrldYXqKGOCC1moZk-ZElVOaNWc3KTTraKg7kpV-1JVKVXdl6q6Imr3olzgcInpt_V_VD8ABZegzQ</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Paparo, Francesco</creator><creator>Peirano, Alice</creator><creator>Matos, João</creator><creator>Bacigalupo, Lorenzo</creator><creator>Rossi, Umberto</creator><creator>Mussetto, Ilaria</creator><creator>Bottoni, Gianluca</creator><creator>Ugolini, Martina</creator><creator>Introini, Carlo</creator><creator>Ruggieri, Filippo Grillo</creator><creator>Rollandi, Gian Andrea</creator><creator>Piccardo, Arnoldo</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2391-0635</orcidid></search><sort><creationdate>20201101</creationdate><title>Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI</title><author>Paparo, Francesco ; Peirano, Alice ; Matos, João ; Bacigalupo, Lorenzo ; Rossi, Umberto ; Mussetto, Ilaria ; Bottoni, Gianluca ; Ugolini, Martina ; Introini, Carlo ; Ruggieri, Filippo Grillo ; Rollandi, Gian Andrea ; Piccardo, Arnoldo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1977-2615010ffa56db89951f03ca35061610597953651ed8cde49f14a84ca4cfbcf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer surgery</topic><topic>Choline</topic><topic>Computed tomography</topic><topic>Diagnostic systems</topic><topic>Fluorine isotopes</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Imaging</topic><topic>Magnetic resonance imaging</topic><topic>Medical diagnosis</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pelvis</topic><topic>Positron emission</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Radiation therapy</topic><topic>Radiology</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paparo, Francesco</creatorcontrib><creatorcontrib>Peirano, Alice</creatorcontrib><creatorcontrib>Matos, João</creatorcontrib><creatorcontrib>Bacigalupo, Lorenzo</creatorcontrib><creatorcontrib>Rossi, Umberto</creatorcontrib><creatorcontrib>Mussetto, Ilaria</creatorcontrib><creatorcontrib>Bottoni, Gianluca</creatorcontrib><creatorcontrib>Ugolini, Martina</creatorcontrib><creatorcontrib>Introini, Carlo</creatorcontrib><creatorcontrib>Ruggieri, Filippo Grillo</creatorcontrib><creatorcontrib>Rollandi, Gian Andrea</creatorcontrib><creatorcontrib>Piccardo, Arnoldo</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Abdominal imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paparo, Francesco</au><au>Peirano, Alice</au><au>Matos, João</au><au>Bacigalupo, Lorenzo</au><au>Rossi, Umberto</au><au>Mussetto, Ilaria</au><au>Bottoni, Gianluca</au><au>Ugolini, Martina</au><au>Introini, Carlo</au><au>Ruggieri, Filippo Grillo</au><au>Rollandi, Gian Andrea</au><au>Piccardo, Arnoldo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI</atitle><jtitle>Abdominal imaging</jtitle><stitle>Abdom Radiol</stitle><date>2020-11-01</date><risdate>2020</risdate><volume>45</volume><issue>11</issue><spage>3896</spage><epage>3906</epage><pages>3896-3906</pages><issn>2366-004X</issn><eissn>2366-0058</eissn><abstract>Purpose
To assess the diagnostic value of retrospectively fused PET/MRI by comparing the detection rates (DRs) of fused
64
CuCl
2
PET/MRI vs. fused
18
F-Choline PET/MRI in patients with suspected prostatic cancer (PCa) recurrence. The secondary objective was to compare the DRs of fused PET/MRI vs. those of the separate imaging modalities.
Methods
We retrospectively evaluated 50 PCa patients with biochemical relapse after radical prostatectomy (RP) or radiotherapy (RT). All patients underwent
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and multiparametric magnetic resonance imaging (mpMRI) within 15 days. Fused
64
CuCl
2
-PET/MRI and fused
18
F-Choline PET/MRI images were obtained by retrospective co-registration of MRI and PET images. Experienced readers interpreted the images, and the DRs of each imaging modality were assessed.
Results
In the patient-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 88%, 68%, 82%, 56%, and 74%, respectively. In the lesion-based analysis, overall DRs of fused
64
CuCl
2
PET/MRI, fused
18
F-Choline PET/MRI,
64
CuCl
2
PET/CT,
18
F-Choline PET/CT, and mpMRI were 95%, 66%, 87%, 58%, and 71%, respectively.
Conclusions
Retrospectively fused PET/MRI is able to overcome the limitations of the separate interpretation of the individual imaging modalities. Fused
64
CuCl
2
PET/MRI provided the highest diagnostic performance in the detection of PCa local relapse.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s00261-020-02591-7</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-2391-0635</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2366-004X |
| ispartof | Abdominal imaging, 2020-11, Vol.45 (11), p.3896-3906 |
| issn | 2366-004X 2366-0058 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2406949588 |
| source | SpringerLink Journals |
| subjects | Cancer surgery Choline Computed tomography Diagnostic systems Fluorine isotopes Gastroenterology Hepatology Imaging Magnetic resonance imaging Medical diagnosis Medical imaging Medicine Medicine & Public Health Pelvis Positron emission Prostate cancer Prostatectomy Radiation therapy Radiology Tomography |
| title | Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T11%3A51%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%20retrospectively%20fused%2064CuCl2%20PET/MRI%20in%20biochemical%20relapse%20of%20prostate%20cancer:%20comparison%20with%20fused%2018F-Choline%20PET/MRI,%2064CuCl2%20PET/CT,%2018F-Choline%20PET/CT,%20and%20mpMRI&rft.jtitle=Abdominal%20imaging&rft.au=Paparo,%20Francesco&rft.date=2020-11-01&rft.volume=45&rft.issue=11&rft.spage=3896&rft.epage=3906&rft.pages=3896-3906&rft.issn=2366-004X&rft.eissn=2366-0058&rft_id=info:doi/10.1007/s00261-020-02591-7&rft_dat=%3Cproquest_cross%3E2471446569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471446569&rft_id=info:pmid/&rfr_iscdi=true |